Walsh P N, Lipscomb M S
Br J Haematol. 1976 May;33(1):9-18. doi: 10.1111/j.1365-2141.1976.tb00967.x.
The coagulant activities of various phospholipid preparations were compared with those of platelets. Folch phospholipid with maximal platelet factor 3 (PF3) activity produced long recalcified clotting times of relatively undiluted plasma in plastic tubes whereas untreated or ADP-treated platelets with minimal PF3 activity produced short clotting times in the same test system which is sensitive to activators of the contact system of intrinsic coagulation. Bell and Alton phospholipids with maximal PF3 activity produced recalcified clotting times similar to those in the presence of platelets. Bell and Alton phospholipids had tissue factor activity, but Folch phospholipid and platelets did not. Bell and Alton phospholipids and gum acacia (used as a vehicle in one of the preparations) activated factor XII as did platelets, but Folch phospholipid did not. The multiple coagulant activities of Bell and Alton phospholipids (i.e. PF3, tissue factor and contact activating) may account for the absence of coagulant superiority of platelets in the undiluted system in plastic tubes. The coagulant activities of platelets are also complex but different from Bell and Alton phospholipids whereas Folch phospholipid would appear to possess only PF3 activity.
将各种磷脂制剂的凝血活性与血小板的凝血活性进行了比较。具有最大血小板因子3(PF3)活性的福尔克磷脂在塑料管中使相对未稀释的血浆的再钙化凝血时间延长,而具有最小PF3活性的未处理或ADP处理的血小板在对内源性凝血接触系统激活剂敏感的相同测试系统中产生较短的凝血时间。具有最大PF3活性的贝尔和奥尔顿磷脂产生的再钙化凝血时间与存在血小板时相似。贝尔和奥尔顿磷脂具有组织因子活性,但福尔克磷脂和血小板没有。贝尔和奥尔顿磷脂以及阿拉伯树胶(在一种制剂中用作赋形剂)与血小板一样能激活因子XII,但福尔克磷脂不能。贝尔和奥尔顿磷脂的多种凝血活性(即PF3、组织因子和接触激活)可能解释了在塑料管中的未稀释系统中血小板不存在凝血优势的原因。血小板的凝血活性也很复杂,但与贝尔和奥尔顿磷脂不同,而福尔克磷脂似乎仅具有PF3活性。